• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

AT-406

Gastroesophageal reflux disease (GERD) continues to be an area of active

July 21, 2017 by Katherine Lewis Leave a Comment

Gastroesophageal reflux disease (GERD) continues to be an area of active AT-406 research in the Asia-Pacific region in the recent years. In the past few years there has been an increase in the frequency of GERD in Asia. In a re-survey[5] of community residents who were interviewed in an earlier study in 1994[1] there was … [Read more…]

Posted in: Blogging Tagged: AT-406, Rabbit polyclonal to GAL.

Copyright © 2026 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by